Selvita
Mentions
1
Across all reports
Quality Score
15/ 100
New
First Seen
May 27, 2026
Indexed in atlas
Last Seen
3h ago
Most recent reference
Positioning
Synthesized from 1 mentionSelvita provides fee-for-service virtual screening using their proprietary TADAM AI platform. They target companies that prefer outsourcing over in-house tools. Pricing is project-based, typically $50k-$200k per screen. They also offer integrated drug discovery services.
Strengths
3 cited- Full-service CRO
- AI platform
- Established client base
Weaknesses
3 cited- High cost
- No self-service tool
- Long turnaround
Recent mentions
Showing 1 of 1- adjacent3h ago
Virtual Screening Platform for Drug Discovery Teams
virtualscreeningplatformdrugdiscoveryteams
Validate something like Selvita
Use Selvita as a starting point and let Unycorn map adjacent opportunities, underserved segments, and feature gaps worth pursuing.